Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT06481813 2026-01-21

BREATHE

730 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06923618 2025-12-15

CLASSE-P1

385 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03958240 2025-09-15

DECIDE

GastrointestinalGynecologicHead & NeckThoracic

1,100 enrolled

Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms

NCT05091190 2025-09-11

MADMAS

Phase NA Active not recruiting

75 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT06247826 2025-08-04

RESAMEX

30 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06711770 2025-07-30

CIRCUIT

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05251805 2025-06-08

The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery

4 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT04222335 2024-07-03

LUNG-RESIST

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05602259 2024-02-09

PROTEON

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05426317 2022-06-22

Onco-PDL1s/B2M

DermatologicGenitourinaryThoracic

100 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT03998189 2021-11-05

Metabolic and Microbial Profiling of Lung Cancer

1 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT00685750 2019-06-20

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

88 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT03771404 2018-12-11

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02105168 2016-06-10

MSN

2,200 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Small Cell Lung Carcinoma

NCT01658332 2015-07-30

CIRCUBRONCH

59 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Phase NA Completed

6 enrolled 6 charts